By Mauro Orru
The U.K.'s Competition and Markets Authority is considering whether a deal for Roche Holding to buy certain companies linked to LumiraDx's point-of-care technology could stifle competition in the country.
The CMA said Monday that it is seeking comments from any interested party until June 3 to inform its views on the deal, though it hasn't yet launched a formal investigation into the transaction.
Roche and LumiraDx struck an agreement in December. The companies didn't respond to requests for comment.
Write to Mauro Orru at mauro.orru@wsj.com
(END) Dow Jones Newswires
05-20-24 0238ET